Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions
Constipation
Interventions
DRUG

MD-1100 Acetate

Trial Locations (14)

14534

Chung H. Kim, MD, Pittsford

23454

East Coast Clinical Research, LLC, Virginia Beach

27408

Vital Research, Greensboro

33426

Consultants for Clinical Research of South Florida, Boynton Beach

35801

Clinical Research Associates, Huntsville

37304

ClinSearch, Chattanooga

38120

Memphis Gastroenterology Clinic, Germantown

72117

Arkansas Gastroenterology, North Little Rock

73112

Sooner Clinical Research, Oklahoma City

75110

Trinity Clinic - Corsicana, Corsicana

78745

Austin Gastroenterology, P.A., Austin

98506

Vantage Clinical Research, Olympia

02215

Beth Israel Deaconess Medical Center, Boston

27599-7080

UC for Functional GI & Motility Disorders, Chapel Hill

Sponsors
All Listed Sponsors
lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY